Laminin-binding to dystroglycan in the dystrophin glycoprotein complex2 causes signaling through dystroglycan-syntrophin-grb2-SOS1-Rac1-PAK1-JNK. Laminin-binding also causes syntrophin tyrosine phosphorylation to initiate signaling. The kinase responsible was investigated here. PP2 and SU6656, specific inhibitors of Src family kinases, decreased the amount of phosphotyrosinesyntrophin and decreased active Rac1 in laminin-treated myoblasts, myotubes or skeletal muscle microsomes. c-Src and c-Fyn both phosphorylate syntrophin and inhibition of either with specific siRNAs diminish syntrophin phosphorylation. When the rat gastrocnemius was contracted, Rac1 activation increased compared to the relaxed control muscle and Rac1 co-localized with β-dystroglycan. Similar results were obtained when the muscle was stretched. Contracted muscle also contained more activated c-Jun N-terminal Kinase, JNKp46. E3, an expressed protein containing only laminin domains LG4-5, increased proliferation of myoblasts and PP2 prevented cell proliferation. In addition, Src family kinases co-localized with activated Rac1 and with lamininSepharose in solid-phase binding assays. Thus, contraction, stretching, or laminin-binding cause Srcfamily kinase recruitment to the dystrophin glycoprotein complex, activating Rac1 and inducing downstream signaling. The DGC likely represents a mechanoreceptor in skeletal muscle regulating muscle growth in response to muscle activity. Src-family kinases play an initiating and critical role.In skeletal muscle, dystrophin, dystroglycan and syntrophins are found in the dystrophin glycoprotein complex, whose defects cause muscular dystrophies. Duchenne muscular dystrophy is the absence of dystrophin and the most common progressive muscle-wasting disease in human (1). Congenital muscular dystrophy results from alterations in laminindystroglycan interaction (2). Either type of muscular dystrophy would disrupt the normal DGC interaction with laminin. We showed that laminin binding causes signaling through dystroglycan-syntrophin-grb2-SOS1-Rac1-PAK1-JNK that ultimately results in the phosphorylation of c-jun on Ser 63 (3). We have proposed that this or other cell signaling, which results from the DGC-laminin interaction, may serve a role in these pathologies. Although many activities of the DGC are known, its function is unclear.1 This work was supported by the National Institutes of Health (grant AR051440) and the Muscular Dystrophy Association (grant 3789).2 Abbreviations Used: DGC, dystrophin glycoprotein complex; JNKp46, the 46,000 molecular mass isoform of c-Jun N-terminal Kinase;LG, laminin globular domains; E3, an expressed protein containing only α1-laminin domains LG4-5; αDG , α-dystroglycan; βDG , β-dystroglycan; αSG, α-sarcoglycan; Syn, syntrophin; PCR, polymerase chain reaction; DMEM, Dulbecco's modified Eagle's medium; GST, glutathione S-transferase; PAK1, p21-activated kinase; Laminin is an αβγ heterotrimer. It binds to both dystroglycan and integrins in five globular domains (i.e., LG domains)...